Texas House Sends Psychedelics Research To Governor’s Desk
The Texas House approved a budget amendment to the psychedelics research bill advancing it to the Governor’s desk.
The bill, HB 1802, requires the Department of State Health Services and Texas Medical Board to research the medical benefits and efficacy of psilocybin, MDMA, and ketamine when treating various mental health disorders and other ailments. The study will be conducted in partnership with Baylor College of Medicine and will focus on veterans suffering from post-traumatic stress disorder (PTSD).
Some of the other disorders include chronic pain, anxiety, depression, bipolar disorders, PTSD and migraines. Under the bill, the Health Department is expected to submit the results of the research with recommendations for further legislative actions on December 1, 2022.
Connecticut Cannabis Legalization Bill Backed By The Governor Passes Another Committee
The Connecticut cannabis legalization measure supported by Gov. Ned Lamont passed another committee, possibly opening the doors for a floor vote in the coming week, reported Marijuana Moment.
The bill was approved in a 29-18 vote by the Appropriations Committee, following the approval of the Judiciary Committee in May.
In addition to this bill, backed by Lamont, there is also another legalization proposal sponsored by Rep. Robyn Porter. The Porter-backed bill is praised by supporters for its social equity clauses.
Legislative leaders still hope to come up with a combined bill that would be supported by both the governor and lawmakers.
“House Majority Leader Jason Rojas (D) said on Tuesday that the plan was to reach an agreement by the week’s end, with the expectation of ‘acting on it sometime next week’ in the Senate.”
Earlier this month, Lamont noted that if a legalization measure doesn’t get enacted this year it could reach the voters, reported the outlet.
Illinois Senate Advances Cannabis Equity Licensing Bill To Governor’s Desk
The bill aims to advance the 2019 Cannabis Regulation and Tax Act regarding a license lottery that had been delayed by the pandemic, controversy, and legal disputes for more than a year. Changes to the bill, sponsored by Chicago Rep. La Shawn Ford (D) would set up two new cannabis dispensary lotteries awarding 55 licenses each as compared to the initial lottery, which was set to award 75 in total.
The original lottery had many difficulties, aside from delays with only 21 out of more than 900 applicants obtaining an ideal score to qualify for the lottery.
After passing the Senate, Gov. JB Pritzker said he is eager to sign the bill “so that we can begin the next phase creating a cannabis industry that reflects the diversity of all of our people.”
Nevada Senate Approves Measure To Legalize Cannabis Consumption Lounges
The Nevada Senate approved the cannabis consumption lounges legalization bill in a 17-3 vote Monday, sending it to the governor’s desk, reported Marijuana Moment.
The bill, sponsored by Assemblyman Steve Yeager (D) would set up two new licensing categories for cannabis businesses – 1) ”retail cannabis consumption lounges and 2) “independent cannabis consumption lounges.”
Considering that Gov. Steve Sisolak (D) supports the state’s cannabis industry, advocates are expecting him to sign the measure. Last year, Sisolak pardoned more than 15,000 people with records for low-level cannabis possessions.
Insomnia And Autism To Be Legally Treated With Medical Cannabis In New Hampshire
New Hampshire Gov. Chris Sununu (R) placed his signature on a bill that would broaden the list of qualifying conditions for the state’s medical cannabis program, reported Merry Jane.
The bill will become law on July 21st, enabling doctors to recommend medical cannabis to adults suffering from insomnia or autism spectrum disorder (ASD). Furthermore, physicians will be able to recommend medical cannabis to minors with ASD in the event that conventional medications can be proven to be ineffective.
Tennessee Governor Signs Medical Cannabis Expansion Bill, Turns It Into Law
Tennessee Gov. Bill Lee signed a narrow medical cannabis expansion bill, SB 118, into law, reports NORML. The new law takes effect immediately.
Under this law, patients that qualify for medical cannabis products could legally use products with no more than 0.9% THC. In-state production does not fall under this law.
Originally the measure included only intractable epilepsy as a qualifying medical condition, but with this new measure, the following conditions are being added: Alzheimer’s disease; ALS; end-stage cancer or when conventional treatment causes such responses as nausea, vomiting, and pain; IBS including Crohn’s disease and ulcerative colitis; epilepsy or seizures; multiple sclerosis; Parkinson’s disease; HIV or AIDS and sickle cell disease.
Furthermore, the new law would set up a commission to analyze federal and state medical cannabis laws in order to advise lawmakers on future medical cannabis legislation actions in the state once the cannabis is rescheduled or removed from its Schedule I status of the Controlled Substances Act.
The report from the commission is expected to be submitted by January 2022.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.
All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.
Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.
Rate collection and criteria: Click here for more information on rate collection and criteria.